HIF hydroxylation and the mammalian oxygen-sensing pathway
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Hypoxia refers to below-normal levels of oxygen in air, blood, or tissue.Tissue hypoxia leads to cellular dysfunction and ultimately can lead to cell death.Causes of tissue hypoxia include (a) decreased blood oxygenation (such as occurs in certain pulmonary disorders), (b) altered oxygen release from hemoglobin (associated with some hemoglobinopathies), and (c) impaired blood delivery leading to localized anemia (i.e., ischemia) as a result of low cardiac output or vascular obstruction.In order to adapt to hypoxia, mammals use a number of physiological responses.These include (a) increased production of erythropoietin (EPO), which augments the production of red blood cells; (b) induction of tyrosine hydroxylase, which facilitates the control of ventilation through the carotid body; and (c) the stimulation of new blood vessels by upregulation of VEGF (1).At the cellular level, hypoxia induces a number of metabolic changes that allow for continued energy generation despite decreased oxygen availability. Hypoxia-inducible factorOne of the most important factors in the cellular response to hypoxia is hypoxia-inducible factor (HIF), which transcriptionally activates genes encoding proteins that mediate adaptive responses to reduced oxygen availability.HIF is a heterodimer consisting of one of three α subunits (HIF1-α, HIF2-α, or HIF3-α) bound to the aryl hydrocarbon receptor nuclear translocator (ARNT), which is also known as HIF1-β.HIF-α is a member of the basic helix-loop-helix (bHLH) superfamily, in which the HLH domain mediates sub-unit dimerization while the basic domain binds to DNA.HIF-α, like some other bHLH family members, contains a Per/Arnt/Sim (PAS) domain that facilitates the heterodimerization of HIF-α with ARNT (2-4).HIF target genes play critical roles in metabolism, angiogenesis, cell proliferation, and cell survival.Examples of HIF target genes include VEGF, glucose transporter 1 (GLUT1), and EPO.HIF binds to the hypoxia-responsive element, which contains the core recognition sequence 5′-TACGTG-3′ (5), in the cis-regulatory regions of hypoxia-inducible genes.Transcriptional activation by HIF is linked to its ability to recruit coactivator proteins such as CREB-binding protein (CBP), p300, steroid receptor coactivator-1, and translation initiation factor 2 (6-8).Whereas changes in oxygen levels do not affect ARNT protein levels, hypoxia markedly increases the abundance of the HIF-α subunits (9-11).This increase is due primarily to protein stabilization.In some settings, hypoxia also leads to increased HIF1-α mRNA accumulation (12,13).von Hippel-Lindau disease von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome that affects approximately 1 in 35,000 individuals.The syndrome was first described in 1894 by Collins, who observed two siblings with bilateral retinal angiomas (now also called hemangioblastomas) (14).Later, the disease was mapped to chromosome 3p25 (15), and the VHL gene itself was isolated in 1993 (16).VHL behaves as a classical tumor suppressor gene.Almost all individuals with a clinical diagnosis of VHL disease can be shown to harbor a germline mutation of the VHL gene, with tumor development linked to somatic inactivation or loss of the remaining wild-type allele (17).The cardinal features of VHL disease are blood vessel tumors of the retina and central nervous system.Other tumors associated with VHL disease include clear cell carcinomas of the kidney, pheochromocytoma, endolymphatic sac tumors, pancreatic islet cell tumors, and papillary cystadenomas of the epididymis (in males) or broad ligament (in females) (18).In addition, patients with VHL often develop multiple visceral cysts involving organs such as the pancreas and kidneys (18).Biallelic VHL inactivation also occurs commonly in patients with sporadic hemangioblastoma or renal cell carcinoma,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Safran and Kaelin, 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Research works printed but not linked: 3
- Collins, E.T. 1894. Intra-ocular growth (two cases, brother and sister, with peculiar new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. U. K. 14 :141-149.
- Clifford, S.C., Prowse, A.H., Affara, N.A., Buys, C.H., and Maher, E.R. 1998. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer. 22 :200-209. · DOI · Paper page
- Yang, J., Haworth, S., Steinberg, S., Rosenberg, S., and Novotny, W. 2002. A randomized double-blind placebo-controlled trail of bevacizumab (anti-VEGF antibody) demonstrating a prolongation in time to progression in patients with metastatic renal cancer. Proc. Am. Soc. Clin. Oncol. 21 :15 (Abstr.).
Cited by
Items 201–300 of 375
RNA interference technology for anti-VEGF treatment
Chen, S., Feng, J., Ma, L., Liu, Z., & Yuan, W. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.926886 · Cited by 28
Hypoxia during incubation and its effects on broiler's embryonic development
Haron, A., Ruzal, M., Shinder, D., & Druyan, S. (2021) · Poultry Science · doi:10.1016/j.psj.2020.12.048 · Cited by 32
Regulation of the HIF switch in human endothelial and cancer cells
Slawski, J., Jaśkiewicz, M., Barton, A., Kozioł, S., Collawn, J. F., & Bartoszewski, R. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151386 · Cited by 26
Martín-Puig, S., Tello, D., & Aragonés, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00137 · Cited by 31
Moehlenbrink, J., Bitomsky, N., & Hofmann, T. G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.11.016 · Cited by 32
Analysis of a Mathematical Model of Ischemic Cutaneous Wounds
Friedman, A., Hu, B., & Xue, C. (2010) · SIAM Journal on Mathematical Analysis · doi:10.1137/090772630 · Cited by 28
Cao, Y.-B., Chen, X., Wang, S., Wang, Y.-X., & Du, J.-Z. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9175-4 · Cited by 29
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth
Cantelmo, A. R., Cammarota, R., Noonan, D. M., Focaccetti, C., Comoglio, P. M., Prat, M., & Albini, A. (2010) · Oncogene · doi:10.1038/onc.2010.267 · Cited by 25
Ma, H., Sun, D., Ju, L., & Yin, Z. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.03.013 · Cited by 25
Pathophysiology of Diabetic Retinopathy
Stewart, M. W. (2010) · Springer eBooks · doi:10.1007/978-0-387-85900-2_1 · Cited by 30
Frohn, M., Viswanadhan, V. N., Pickrell, A. J., Golden, J. E., Muller, K. M., Bürli, R. W., Biddlecome, G. H., Yoder, S. C., Rogers, N. E., Dao, J. H., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.012 · Cited by 26
Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors
Korpanty, G. J., Sullivan, L. A., Smyth, E. C., Carney, D. N., & Brekken, R. A. (2010) · Journal of Oncology · doi:10.1155/2010/652320 · Cited by 28
Nguyen‐Khac, F., Della-Valle, V., Lopez, R. G., Ravet, E., Mauchauffé, M., Friedman, A. D., Huang, E. L., Fichelson, S., Ghysdael, J., & Bernard, O. (2006) · Oncogene · doi:10.1038/sj.onc.1209503 · Cited by 25
The impact of mitochondria on cancer treatment resistance
van der Merwe, M., van Niekerk, G., Fourie, C., du Plessis, M., & Engelbrecht, A. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00623-y · Cited by 26
Nikitenko, L. L., & Boshoff, C. (2006) · Springer eBooks · doi:10.1007/3-540-36028-x_10 · Cited by 26
Ogura, M., Shibata, T., Yi, J., Liu, J., Qu, R., Harada, H., & Hiraoka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00044.x · Cited by 26
Zhang, B., Liang, X., Shi, W., Ye, Z., He, C., Hu, X., & Liu, S. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00412.x · Cited by 24
Yu, D. B., Zhong, S. Y., Yang, M., Wang, Y. G., Qian, Q., Zheng, S. S., & Liu, X. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01110.x · Cited by 22
Egorova, A., Shtykalova, S., Maretina, M. A., Соколов, Д. И., Selkov, S. А., Баранов, В. С., & Kiselev, A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060261 · Cited by 23
Korpanty, G. J., & Smyth, E. C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626166 · Cited by 24
Unraveling the epigenomic and transcriptomic interplay during alcohol-induced anxiolysis
Krishnan, H. R., Zhang, H., Chen, Y., Bohnsack, J. P., Shieh, A. W., Kusumo, H., Drnevich, J. M., Liu, C., Grayson, D. R., Maienschein‐Cline, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01732-2 · Cited by 27
Okamoto, N., Tanaka, A., Jung, K., Karasawa, K., Orito, K., Matsuda, A., Amagai, Y., Oida, K., Ohmori, K., & Matsuda, H. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr203 · Cited by 22
Wang, P.-X., & Sanders, P. W. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00213.2004 · Cited by 20
An Evolutionary Model for Identifying Genetic Adaptation to High Altitude
MOORE, L. G., Shriver, M. D., Bemis, L., & Vargas, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-34817-9_10 · Cited by 21
Liu, D., Cao, G., Cen, Y., Liu, T., Wei, P., Sun, J., Li, X., & Zhou, H. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.002 · Cited by 19
PPARγ Agonists: Emergent Therapy in Endometriosis
Vallée, A., Vallée, J.-N., Blanche, A. F. L., & Lecarpentier, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14060543 · Cited by 19
Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes
Lamirand, A., MERCIER, G., Ramaugé, M., Pierre, M., & Courtin, F. (2007) · Endocrinology · doi:10.1210/en.2007-0625 · Cited by 20
Erez, N., Stambolsky, P., Shats, I., Milyavsky, M., Kachko, T., & Rotter, V. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.003 · Cited by 23
Yeo, H., & Lim, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111650 · Cited by 19
Keglowich, L., Baraket, M., Tamm, M., & Borger, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089875 · Cited by 18
Dong, X., Qu, W.-Z., Ma, S., Zhu, Z., Zheng, C., He, A., Karlsson, A., Xu, K., & Zheng, X. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.09.003 · Cited by 18
Corner, T. P., Teo, R. Z. R., Wu, Y., Salah, E., Nakashima, Y., Fiorini, G., Tumber, A., Brasnett, A., Holt‐Martyn, J. P., Figg, W. D., et al. (2023) · Chemical Science · doi:10.1039/d3sc04253g · Cited by 19
Yoon, D., Okhotin, D., Kim, B., Okhotina, Y., Okhotin, D. J., Miasnikova, G., Sergueeva, A., Polyakova, L. A., Maslow, A., Lee, Y., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0599-0 · Cited by 19
Locatelli, F., Vecchio, L. D., & Elliott, S. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad105 · Cited by 17
Mass spectrometric characterization of mitochondrial complex I NDUFA10 variants
Muñoz, J., Fernández‐Irigoyen, J., Santamaría, E., Parbel, A., Obeso, J. A., & Corrales, F. J. (2008) · PROTEOMICS · doi:10.1002/pmic.200701085 · Cited by 17
An Oxygen Molecular Sensor, the HIF Prolyl 4-Hydroxylase, in the Marine Protist Perkinsus olseni
Leite, R. B., Bensimon‐Brito, A., & Cancela, M. L. (2008) · Protist · doi:10.1016/j.protis.2008.03.002 · Cited by 17
The role of hypoxia inducible factor-1 in cell metabolism – a possible target in cancer therapy
Aiba, R. S. B., Dimova, E. Y., Görlach, A., & Kietzmann, T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.583 · Cited by 19
A Phenotypic Perspective on Mammalian Oxygen Sensor Candidates
Baysal, B. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.024 · Cited by 20
Protein Kinase C-Mediated Modulation of FIH-1 Expression by the Homeodomain Protein CDP/Cut/Cux
Li, J., Wang, E., Dutta, S. K., Lau, J. S., Jiang, S., Datta, K., & Mukhopadhyay, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02201-06 · Cited by 18
Rad, F. H., Ulusakarya, A., Gad, S., Sibony, M., Juin, F., Richard, S., Machover, D., & Uzan, G. (2007) · American Journal of Hematology · doi:10.1002/ajh.21019 · Cited by 16
Liu, E. Y. L., Zheng, Z. X., Zheng, B. Z.-Y., Xia, Y., Guo, M. S., Dong, T. T.-X., & Tsim, K. W. K. (2019) · Phytotherapy Research · doi:10.1002/ptr.6599 · Cited by 16
Increased transferrin protects from thrombosis in Chuvash erythrocytosis
Shah, B. N., Zhang, X., Sergueeva, A., Miasnikova, G., Ganz, T., Prchal, J. T., & Gordeuk, V. R. (2023) · American Journal of Hematology · doi:10.1002/ajh.27021 · Cited by 16
Targeting the mTOR Pathway in Tumor Malignancy
Cheng, H., Walls, M., Baxi, S. M., & Yin, M.-J. (2013) · Current Cancer Drug Targets · doi:10.2174/1568009611313030005 · Cited by 18
The heart is lost without the hypothalamus
Pyner, S. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00024-1 · Cited by 16
Seystahl, K., Weller, M., Bozinov, O., Reimann, R., & Rushing, E. J. (2014) · Oncology Research and Treatment · doi:10.1159/000360780 · Cited by 15
Sun, D., Liu, C., Ma, H., & Zhang, L. (2011) · Renal Failure · doi:10.3109/0886022x.2010.541586 · Cited by 14
Thevis, M., Thomas, A., Kohler, M., Beuck, S., Möller, I., Schäfer, M., Rodchenkov, G. M., Yin, S. H., Loo, J. A., Geyer, H., et al. (2010) · European Journal of Mass Spectrometry · doi:10.1255/ejms.1047 · Cited by 15
Su, M., Huang, J., Li, J., Qin, X., Tang, X., Jin, F., Chen, S., Jiang, C., Zou, Z., Peng, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7968 · Cited by 14
Emerging drugs for the treatment of kidney disease-induced anemia
Małyszko, J., & Małyszko, J. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1220537 · Cited by 14
An integrative model for vascular endothelial growth factor A as a tumour biomarker
Latham, A. M., Molina-París, C., Homer‐Vanniasinkam, S., & Ponnambalam, S. (2010) · Integrative Biology · doi:10.1039/c0ib00008f · Cited by 14
Zhang, S., Xu, H., Li, W., Ji, J., Jin, Q., Chen, L., Gan, Q., Tao, Q., & Chai, Y. (2023) · Pathology & Oncology Research · doi:10.3389/pore.2023.1610801 · Cited by 13
Zhao, H., Zhang, Q., Yang, Y., Lu, M.-Q., Li, H., 徐池, & Chen, G.-H. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i5.683 · Cited by 13
Molecular Targets for Promoting Wound Healing in Diabetes
Pradhan, L., Andersen, N. D., LoGerfo, F. W., & Veves, A. (2007) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221407779814589 · Cited by 14
DeMichele, E., Sosnowski, O., Buret, A. G., & Allain, T. (2023) · Microorganisms · doi:10.3390/microorganisms11061598 · Cited by 11
Bartel, R. L., Booth, E. A., Cramer, C., Ledford, K., Watling, S., & Zeigler, F. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9431-x · Cited by 15
Mint3 as a Potential Target for Cooling Down HIF-1α-Mediated Inflammation and Cancer Aggressiveness
Tanaka, N., & Sakamoto, T. (2023) · Biomedicines · doi:10.3390/biomedicines11020549 · Cited by 12
Pathophysiology of Retinal Vein Occlusions
Browning, D. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3439-9_2 · Cited by 11
Sellathurai, J., Nielsen, J., Hejbøl, E. K., Jørgensen, L. H., Dhawan, J., Nielsen, M. F. B., & Schrøder, H. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158860 · Cited by 12
Escudero, C., & Calle, A. (2006) · Revista médica de Chile · doi:10.4067/s0034-98872006000400014 · Cited by 12
Martín-Puig, S., Temes, E., Olmos, G., Jones, D., Aragonés, J., & Landázuri, M. O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310658200 · Cited by 12
Kudo, J., Hirono, H., & Ohkoshi, S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151744 · Cited by 12
Bartels, M., van der Zalm, M. M., van Oirschot, B. A., Lee, F. S., Giles, R. H., Kruip, M. J. H. A., Gitz-Francois, J. J., van Solinge, W. W., Bierings, M., & van Wijk, R. (2015) · Human Mutation · doi:10.1002/humu.22846 · Cited by 10
Strategies for Conditional Regulation of Proteins
Nadendla, K., Simpson, G. G., Becher, J. B., Journeaux, T., Cabeza-Cabrerizo, M., & Bernardes, G. J. L. (2023) · JACS Au · doi:10.1021/jacsau.2c00654 · Cited by 11
Anti-proliferative effects of gold nanoparticles functionalized with Semaphorin 3F
Tan, G., & Onur, M. A. (2017) · Journal of Nanoparticle Research · doi:10.1007/s11051-017-3967-7 · Cited by 10
Liang, S., Medina, E. A., Li, B., & Habib, S. L. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12370 · Cited by 12
Seven in Absentia E3 Ubiquitin Ligases: Central Regulators of Neural Cell Fate and Neuronal Polarity
Ong, T., & Solecki, D. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00322 · Cited by 9
Métabolisme du glucose en situation pathologique aiguë
Losser, M.-R., Damoisel, C., & Payen, D. M. (2009) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2009.02.027 · Cited by 9
Ferrara, N. (2004) · International Congress Series · doi:10.1016/j.ics.2003.11.003 · Cited by 10
Angiotensin II Differentially Regulates Morg1 Expression in Kidney Cells
Bondeva, T., Heinzig, J., Franke, S., & Wolf, G. (2012) · American Journal of Nephrology · doi:10.1159/000337922 · Cited by 9
The Superfamily of SCAN Domain Containing Zinc Finger Transcription Factors
Collins, T., & Sander, T. L. (2005) · Springer eBooks · doi:10.1007/0-387-27421-9_22 · Cited by 8
Salomón-Andonie, J., Miasnikova, G., Sergueeva, A., Polyakova, L. A., Niu, X., Nekhai, S. A., & Gordeuk, V. R. (2013) · Blood · doi:10.1182/blood-2013-07-515973 · Cited by 9
Vascular Permeability/Vascular Endothelial Growth Factor
Shibuya, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_8 · Cited by 8
Functional pathway mapping analysis for hypoxia-inducible factors
Chuang, C.-S., Pai, T., Hu, C., Tzou, W., Chang, M. D., Chang, H., & Chen, C.-C. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s3 · Cited by 8
Peritubular Capillary Loss Is Ameliorated by Ramipril or Valsartan Treatment
Zhang, B., Chen, N., Shi, W., Wang, W., Shi, H., & Yu, H. (2008) · Microcirculation · doi:10.1080/10739680701743540 · Cited by 7
Distinct Stress Regulators in the CRL Family: Emerging Roles of F‐Box Proteins
Hwang, J., Lauinger, L., & Kaiser, P. (2025) · BioEssays · doi:10.1002/bies.202400249 · Cited by 7
In Vitro Evaluation of Vegf-Pseudomonas Exotoxin: A Conjugated on Tumor Cells
Langari, J., Karimipoor, M., Golkar, M., Khanahmad, H., Zeinali, S., Omidinia, S., Cohan, R. A., Behdani, M., Babaie, J., Arezumand, R., et al. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.218691 · Cited by 7
Bioinformatic studies of vertebrate enolases: multifunctional genes and proteins
Holmes, R. S. (2011) · Open Access Bioinformatics · doi:10.2147/oab.s16416 · Cited by 7
Cancer Metabolism and Its Therapeutic Implications
Logsdon, W. L. C. D., & Abbruzzese, J. L. (2013) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000143 · Cited by 9
Zheng, Z. X., Liu, E. Y. L., Wu, Q., Wu, J., Dong, T. T.-X., & Tsim, K. W. K. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110609 · Cited by 6
Krebs cycle enzymes as tumor suppressors
Baysal, B. E. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.012 · Cited by 6
The Oxidative Function of Diferric Transferrin
Crane, F. L., & Löw, H. (2012) · Biochemistry Research International · doi:10.1155/2012/592806 · Cited by 7
Illicit organogenesis: Methods and substances of doping and manipulation
Thevis, M., & Schänzer, W. (2008) · Organogenesis · doi:10.4161/org.4.4.7286 · Cited by 8
Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
Fang, Y., Wang, X., Luo, K., Dakal, T. C., Bai, H., Xu, C., & Zhang, G. (2026) · MedComm · doi:10.1002/mco2.70732 · Cited by 6
Baek, J. H., & Buehler, P. W. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000533 · Cited by 5
Chomette, L., Migeotte, I., Dewachter, C., Vachiéry, J., Smits, G., & Bondue, A. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12052 · Cited by 5
Lastraioli, E., Boni, L., Romoli, M., Crescioli, S., Taddei, A., Beghelli, S., Tomezzoli, A., Vindigni, C., Saragoni, L., Messerini, L., et al. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.03.028 · Cited by 4
Glycolytic Pathway as a Target for Tumor Inhibition
Lu, W., & Huang, P. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_5 · Cited by 4
Rapone, B., & Ferrara, E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90924 · Cited by 4
Chen, F., Li, P., Zhang, F., Chen, H., & Yu, P.-W. (2020) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0136 · Cited by 4
Liu, X., Li, X., Yang, F., Li, Y., Jiao, X., & Xie, P. (2018) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2018.1473386 · Cited by 4
Hou, C., Brasnett, A., Rabe, P., Schofield, C. J., & Brewitz, L. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111008 · Cited by 3
Overview and Clinical Applications of VEGF-A
Ferrara, N. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_30 · Cited by 6
Chapter 13 Oxygen as a Direct and Indirect Biological Determinant in the Vasculature
Huang, Y., & Giordano, F. J. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)02813-9 · Cited by 4
The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls
Morais, C., David, W., & Glenda, C. (2012) · InTech eBooks · doi:10.5772/27009 · Cited by 3
Hypoxie et fonction mitochondriale
Dupic, L., Huet, O., Harrois, A., & Duranteau, J. (2010) · Réanimation · doi:10.1016/j.reaurg.2010.06.006 · Cited by 3
Therapeutic Strategies that Target the HIF System
Cook, K. M., & Schofield, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_32 · Cited by 2
Mechanobiological Modelling of Angiogenesis: Impact on Tissue Engineering and Bone Regeneration
Reina-Romo, E., Valero, C., Borau, C., Rey, R., Javierre, E., Gómez‐Benito, M. J., Domínguez, J., & García‐Aznar, J. M. (2011) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/8415_2011_111 · Cited by 2
Oosterwijk‐Wakka, J. C., Boerman, O. C., Mulders, P., & Oosterwijk, E. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_13 · Cited by 2
Torres, S., Fernández-Checa, J. C., & García‐Ruiz, C. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00012 · Cited by 1
VHL, transferrin, and erythropoietin in the regulation of hepcidin
Sergeev, I., Prchal, J. T., Nouraie, S. M., Shah, B. N., Zhang, X., Sergueeva, A., Miasnikova, G., Ganz, T., & Gordeuk, V. R. (2025) · HemaSphere · doi:10.1002/hem3.70271 · Cited by 1
Metadata
- Authors
- Safran, M., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-03-15
- Volume
- 111
- Issue
- 6
- Pages
- 779-783
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC153778
- OpenAlex
- W2047816152
- Cited by
- 365
- References
- 77
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 11 · 2016: 6 · 2015: 10 · 2014: 16 · 2013: 10 · 2012: 15
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- hypoxia-inducible factor, oxygen sensing, tissue hypoxia, hypoxia-inducible factor-1α, ARNT, bHLH transcription factors, PAS domain, hypoxia response element, transcriptional activation, erythropoietin, vascular endothelial growth factor, glucose transporter 1, angiogenesis
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Asparagine, DNA-Binding Proteins, von Hippel-Lindau Disease, Humans, Hydroxylation, Ligases, Nuclear Proteins, Oxygen, Proline, Repressor Proteins, Transcription Factors, Trans-Activators, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.